in

First Human Trial of HIV Vaccine Produced Immune Response in 97% of Volunteers

A phase 1 clinical trial by IAVI of an experimental mRNA-based vaccine primed the immune system using in order to prevent HIV.

This post was created with our nice and easy submission form. Create your post!

What do you think?

What do you think?

3 ways to address post-pandemic productivity fatigue | The Optimist Daily: Making Solutions the News

6 health benefits of apple cider vinegar | The Optimist Daily: Making Solutions the News